Nordson Corp
NASDAQ:NDSN
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
225
278.89
|
| Price Target |
|
We'll email you a reminder when the closing price reaches USD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Nordson Corp
You don't have any saved screeners yet
Ladies and gentlemen, thank you for standing by, and welcome to the Nordson Corporation's First Quarter Fiscal 2020 Conference Call. [Operator Instructions]
I would now like to hand the conference over to one of your speaker today, Lara Mahoney, please go ahead.
Thank you, Marcela. Good morning. This is Lara Mahoney, Vice President of Corporate Communications and Investor Relations. I'm here with Sundaram Nagarajan, Nordson's President and CEO; and Greg Thaxton, Executive Vice President and CFO. We welcome you to our conference call today, Thursday, February 20th 2020 to report Nordson's fiscal year 2020 first quarter.
Our conference call is being broadcast live on our Investor Relations webpage at investors.nordson.com, and it will be available there for 14 days. There will be a telephone replay of the conference call available until March 5th, 2020, which can be accessed by dialing 416-621-4642. You will need to reference ID number 2468115.
During this conference call, forward-looking statements may be made regarding our future performance based upon Nordson's current expectations. These statements may involve a number of risks, uncertainties and other factors as discussed in the company's filings with the Securities and Exchange Commission that could cause actual results to differ. After our remarks on the quarter, we will be happy to take your questions.
With that, I'll turn the call over to Naga.
Good morning, everyone. Thank you for joining Nordson's 2020 fiscal first quarter conference call. 2020's first quarter performance was in line with our expectations for the quarter where sales were consistent with the typical seasonal pattern. As a reminder, our spending is generally consistent throughout the year due to our direct sales model and strong customer focus. So total company operating margin in the first quarter was also in line with our expectation. We expect sales to improve as we move through the year, allowing us to achieve our previously announced fiscal 2020 sales growth, margin and EPS guide.
I'll speak more about our fiscal 2020 annual guidance in a few moments. But first, I'll turn the call over to Greg to provide more detailed perspective on the quarter.
Thank you, Naga, and good morning to everyone. First quarter sales decreased 1% compared to the prior year's first quarter. Change in sales included a decrease in organic sales of less than 1%, growth from the first year effect of acquisitions of less than 1%, decrease of approximately 1% related to the unfavorable effects of currency translation as compared to the prior year's first quarter.
First quarter's acquisitive growth includes the fiscal 2019 acquisition of Optical Control GmbH. Within the Adhesive Dispensing Systems segment, sales decreased 2% compared to the prior year's first quarter, inclusive of a decrease in organic volume of 1% and a decrease of 1% related to the unfavorable effects of currency translation as compared to the prior year.
Growth in our non-woven product line was offset by modest declines in other product lines segment in the Advanced Technology Systems segment. First quarter sales decreased approximately 1% compared to the prior year's first quarter, inclusive of a decrease in organic volume of 2%, increase of 1% related to the first year effect of the Optical Control acquisition, and decrease of less than 1% related to the unfavorable effects of currency translation as compared to the prior year. Solid growth in medical product lines was offset by softness of those product lines supporting electronic end market.
Industrial Coating Systems segment sales increased 9% compared to the prior year's first quarter, inclusive of organic volume growth of 9% and a decrease of less than 1% related to the unfavorable effects of currency translation as compared to the prior year. Most product lines generated organic growth in the quarter, driven primarily by demand in the US associated with cold materials, outer systems product line.
Moving down the income statement, gross margin for the total company was 53% in the quarter. Operating profit was $75 million with reported operating margin of 15%. During the quarter, we incurred approximately $3 million of restructuring charges as we realigned our cost structure within the Advanced Technology segment. Excluding this charge, total company operating margin was 16% and the Advanced Technology segment operating margin was 15%, down from last year's first quarter operating margin due to lower absorption and product mix impacts on gross margin.
Operating margin performance for the Adhesive and Industrial Coating segments were both equal to the prior year's quarter. On a total company basis, net income for the quarter was $52 million and GAAP diluted earnings per share were $0.89, inclusive of a $0.04 per share charge related to restructuring and a $0.04 per share discrete tax benefit related to stock-based compensation.
We delivered first quarter EBITDA of $101 million or 20% of sales. Excluding restructuring charges in the quarter, EBITDA margin was 21%. Free cash flow before dividends during the quarter was $102 million or 197% of net income. Free cash flow in the quarter benefited from collection of accounts receivable associated with the prior quarter revenue. Our press release includes financial exhibits reconciling net income to free cash flow before dividends and EBITDA, as well as the reconciliation of diluted EPS to adjusted diluted EPS. From a balance sheet perspective, net debt to EBITDA was approximately 1.7 times trailing 12 months EBITDA at the end of the first quarter.
I'll now turn the call over to Naga for a few closing comments.
Thank you, Greg. We remain committed to our annual organic sales growth guidance of 1% to 3% for fiscal 2020 with this growth being generated in the second half of the fiscal year. The incremental revenue will generate improved operating and EBITDA margins as we move through the year where we expect to deliver a total year margin performance equal to fiscal 2019 and EPS growth in the range of 2% to 6% over FY '19. We will continue to monitor the macroeconomic environment, including the impact of coronavirus in the Asia-Pacific region. Our facilities in China are operational and we expect to be closer to full capacity soon.
I want to thank our employees in China for incredibly committed to serving the needs of our customers, along with the rest of the Nordson team, who supported our China employees during the difficult time in many ways. We greatly appreciate all of their efforts, and we'll continue to do all we can to support our employees and their families. Although there may be some impact on sales in our second fiscal quarter as we scale up production, our supply chain recovers, our customers resume operations and delivery schedules return to normal, we do not expect a material impact from coronavirus on our full year results.
Before we open the phone lines for Q&A, I want to share a few observations from my first six months at Nordson. This is a great company that's driven by talented employees who are focused on serving their customers. While we are focused on delivering our near-term 2020 results, we are aligning our internal priorities on the greatest long-term opportunity for this business' profitable growth.
To deliver profitable growth, we have four key priorities. First and foremost, we need to sustain the historical organic growth track record. We'll do this through our focus on innovation, emerging markets and new applications. Second, we need to diversify our business portfolio, including through acquisitions. We'll stay true to what makes us great, which is precision technology. This includes scaling our Medical and Test and Inspection product line. Number three, we need to implement a growth-focused strategic framework that allows us to grow sustainably. I'm pleased that Nordson has a good start on this with the Nordson Business System. With the executive leadership team, we are evaluating how we can take NBS to the next level. I believe there is an opportunity for Nordson in refining and executing on this growth framework. Our fourth priority is folks -- focused on developing a deep and diverse team to support our growth aspirations. I'm pleased with the customer focus team that we have today. As we grow, we will need more of them.
I'm also pleased to announce our plans for an Investor Day in the fall, where we will discuss our long-term plans for the business in more detail. Please mark your calendar for the morning of September 30th, 2020, the event will be focused at the New York Plaza -- Palace Hotel and available through webcast. More information will be available in the coming months. As always, I want to thank our customers, employees and shareholders for their continued support.
With that, we'll pause and take your questions.
[Operator Instructions] Your first question comes from the line of Matt Summerville from D,A. Davidson. Your line is open.
Thanks. Good morning. First of all, can you maybe talk about within the Adhesive business what the organic volume outlook looks like for the balance of the year as the compares in that business get a bit tougher beyond what was an easier comparison in Q1 and in the quarter where organic volume actually declined against that somewhat easy comparison?
Thank you, Matt. We don't provide guidance by segment for organic growth rate. We fully stay committed to our full-year total company guidance of 1% to 3%.
Okay. And then, with respect to maybe the coronavirus, did you see any discernible impact late in your fiscal first quarter, and is there a way to sort of frame up what you think that impact could look like in Q2 and maybe talk about how we should be thinking about the sequential earnings cadence for the company, perhaps if seasonality is pushed a bit to the right here relative to a more normal year?
Matt, I think there were two sort of questions in there, I assume, right. So, the first one is around coronavirus. The impact of awareness in our first quarter was immaterial as we had already planned for the Lunar New Year and had shipments already scheduled and went out in time. We don't expect to have a material impact from coronavirus on our full year results. As we look at it today, we don't see any impact in the second quarter. If there is further disruption in the supply chain or customers having trouble getting back to capacity, there maybe some delay in orders that may get pushed out following quarter. So that is on coronavirus. And I think you had a question around earnings cadence for the company.
Yeah.
Is that correct?
Yeah, yeah. Thank you.
So, our growth is -- based on our typical seasonality, most of our growth always happens in the second quarter -- in the second half, I should say, I'm sorry. So, as we go into second half, this increased revenue will improve and will generate improved operating margins and EBITDA margins that typically have very strong flow through as we have higher sale.
Your next question comes from the line of Jeff Hammond from KeyBanc. Your line is open.
Hey. Good morning, guys. Can you just talk about what you're seeing in electronics as you go into the heavier kind of quoting and order season around 5G infrastructure, 5G mobile and just kind of project inactivity levels going into the year. I know that's something we've been looking for an inflection.
Yeah. As you know, there is a lot of press regarding 5G infrastructure, and we continue to believe that that is where we will see the greatest opportunity. The progress also on infrastructure build out has been slow and slowing. As mentioned before, we don't expect growth in our electronic business compared to fiscal '19 in 2020, that's not what we have forecasted, but our project activities continue to be robust. We are in great conversations. When that wave of 5G infrastructure hits, we will benefit from it. So, as of now, project activities are strong. We continue to be participating in a lot of quoting, timing is what it will be dependent on when those project activities convert into order. And you're right, we are at that point in terms of typical order rates will pick up to have us confidence in delivering that second -- strong second half, and that's what gives us the strength in maintaining our guidance for the full year of 1% to 3%.
And just to add to that, 5G is an important element, of course. It's indicative of change, but we also -- automotive electronics, AI, there are a lot of different applications, which -- where we are diversified.
Okay, great. And then, it looks like the US business was particularly strong in the quarter. What do you see that's working there well?
It is primarily related to our ICS business that has done well. And certainly our Adhesive businesses in US have also continuing to do well.
Okay. And then, just on the second half, so I guess you mentioned some of the project visibility. But other than kind of just typical seasonality, is there anything else in the quoting or activity pipeline that gives you that confidence in kind of an acceleration as you move through the year?
No, it is our typical season seasonality. And we certainly expect -- based on our project activity and our seasonal pattern, we feel pretty strongly about a strong second half, and which we have seen in the past too.
Your next question comes from the line of Christopher Glynn from Oppenheimer. Your line is open.
Thank you. Good morning. Just had a question about the SG&A was beta $9 million sequentially adjusted or unadjusted. And the last five years, typically that spend has been down $5 million or $8 million 4Q to 1Q, so wondering if that indicate some strategic imperative that your kind of front log or pipeline is mandating.
Chris, this is Greg. I wouldn't suggest it's much of what you just talk to there. I would say that the first quarter did have a $2 million one-time cost in the corporate managed -- in the corporate expense line. So that's a non-recurring item. That corporate expense line item, if you were modeling that out, I would expect that to be more around $12.5 million per quarter than in the current quarter. If you back that out, then I think you're looking at a pretty modest increase current year over the prior year. And in the first quarter is a year when -- is the quarter when we have our global compensation increases. So as compared to the fourth quarter, you get a little bit of bump associated with our merit increases hitting in Q1. So if you look at current quarter versus prior year first quarter, it's a pretty modest increase when you exclude that $2 million one-time item.
Okay. So that sort of suggest spending was a bit restrained after the first quarter last year, because I'm looking at -- if you carry the first quarter SG&A spend rates for the year and you get 2% top line growth and SG&A to sales would be up about 100 basis points. So, you're suggesting that's a wrong way to look at it?
Well, what I am -- what I would suggest, Chris is, it is dependent upon that top line growth. If you assume that in our spending over prior year, we're going to have inflationary impact, we're going to have our merit increase, it's the need to generate that top line growth to offset what that dilution might deliver from spending.
Is 1Q the high watermark for SG&A spend on a run rate basis?
Yeah. Given the sales that -- from a seasonal perspective, it's our lowest quarter. That's true.
So as you had sort of spend will be higher in subsequent quarters?
Our spending is fairly flat as you move throughout the year, as Naga mentioned in his comments. With our global infrastructure, we don't flex that based upon seasonality of sales trends. So it's a pretty fixed number as you move through the year. So, in terms of the margin impact, it's more heavily dependent upon the top line sales number.
So first quarter spending was a higher mark for the year.
Sorry, Lara. Can you clarify that? I didn't hear.
I'm just agreeing with you that it is a higher watermark as a percentage of sales to your earlier question, just based on that spend.
Okay. I'll follow up offline. Thanks.
Your next question comes from the line of Allison Poliniak from Wells Fargo. Your line is open.
Hi, guys. Good morning. I just want to go back to your comment, Naga, on just kind of looking at that growth rate mark and sort of maintaining a sustainable growth that Nordson's experienced. Any high level color there of how we should think about that comment? Is it end market? Is it different, I guess, new products, any color there?
I think the strategic growth framework is really, and I will spend a lot of time here, we are building that out as we are enhancing our existing NBS framework. It would be really -- a couple of things that I would add there. That strategic framework is going to be focused on really selecting the best growth opportunities for the company, so really bringing -- bringing forth a strategic view of where we invest and what kind of end market product niches do we want to grow win. So that would be one of the distinguishing factor that will add to the existing growth framework. And the growth framework also consists of things that the company does really, really well, which is commercial excellence, product innovation. So this new great growth framework is really an enhanced version of our existing NBS next. And it adds strategic view of what are the best product market combinations that we want to focus on. So think of that as a greater strategic discipline around where we want to grow, in combination with things that the company is really, really good at, which is commercial excellence, close to the customer model, as well as innovation leading to precision technologies that solves the best problems for our customers.
Great. And thanks for the color on that. And then, on -- thanks for the coronavirus color. It's good to hear things are getting sort of up and running again. Have you -- I mean, are you experiencing any elevated costs as we sort of get back up and running in terms of getting components then or getting projects out as a result of what's going on?
At the present moment, no. Our hope is that the supply changes are continuing to improve as we are seeing. And if this continues over a longer period of time, then there may be some delivery that could get pushed out. But no, on the cost side, we are fairly -- we have good visibility and fairly comfortable. We have very good inventories that will allow us to continue on the path we're on.
[Operator Instructions] Your next question comes from the line of Mark Halloran from Baird. Your line is open.
So, quick question just on the acquisition and M&A side of things. What does the pipeline look like and some of the management changes that now you're a little newer to the scene. And then, with Greg's upcoming departure, does it change your willingness to go after things as it sits here today?
No. We remain committed to our capital allocation strategy. And our priorities there continue to be funding our organic growth, maintaining our dividend streak, acquiring in the spaces that we have expressed an interest in and focused on, which is Medical and Test and Inspection. In terms of acquisition pipeline, we have good opportunities. We continue to work them. When they come to market is something we don't control, but look for us to continue to stay disciplined and focused on what makes the company strong, which is precision technology and two areas as I mentioned earlier that we will remain focused on is Medical and Test and Inspection.
And then, anything in the Industrial Coating side that you'd point to for the strength? It seems mostly comparisons were a little easier and sequential seemed about normal, but anything in there that was unusual or just pretty normal cadence?
It is pretty normal. As you mentioned, the comps were a little easier. There were some project timing, certainly things that we worked on in the fourth quarter certainly helped us in the first quarter, but nothing significant.
There are no further questions at this time, I will turn the call back over to your presenters.
Thank you again for joining us today, and we'll talk to you soon.
This concludes today's conference call. You may now disconnect.